Abstract
Introduction
It has been recently demonstrated (1) (2) (3) (4) (5) that the elderly patients with signs of mineralocorticoid excess may not infrequently show low circulating levels of aldosterone. These abnormalities are similar to those seen in both a syndrome of apparent mineralocorticoid excess (AME) (6, 7) and Liddle's syndrome (8, 9) . Since these syndromes are rare forms of juvenile hypertension due to the mutations of l1β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) gene (7, 10) or of the renal epithelial sodium channel (ENaC) gene (9) , different factors may be operative in the elderly.
In the present paper, 2 elderly women with reduced plasma aldosterone concentrations (PAC), despite the mineralocorticoid excess state, are described, and the abnormalities were investigated in relation to asymptomatic impairment of 11β-HSD2. 
Case Reports

T a b l e 2 . Re s u l t s o f E n d o c r i n e E u n c t i o n T e s t s
KS and 17 OHCS were also normal (Table 2). Suppression of plasma renin activity (PRA) was found (under 0.2 ng/ml/ hour). On the other hand, in the present patient, it was re-
markable that PAC and 24-hour urine aldosterone were markedly decreased (under l0 pg/ml and 0.3-0.8 μg/day, respectively, Table 2 ).
As shown in Fig. 1 , serum potassium levels were elevated to 3.6-4.8 mEq/l and blood pressure returned to normal approximately 1 month after administration of spironolactone, 50-l00 mg per day. Moreover, motor disturbance due to muscle weakness was improved, although she still had gait disturbance. Values for PRA and PAC were also elevated to 20.7 ng/ml/hour and 71.6 pg/ml, respectively. Serum cortisol levels were maintained within the normal range before and after the treatment (Fig. 1) .
These findings suggested that the abnormalities in the present patient were due to impairment of 11β-HSD2 (5) (6) (7) . Therefore, 24-hour urine total cortisol, total cortisone, tetrahydrocortisol (THF), allo-THF and tetrahydrocortisone (THE) were determined twice by urinary steroid profile analysis, using gas chromatography/mass spectrometry in selected ion monitoring (GCMS-SIM) (11) . As shown in Fig. 2 ECG showed complete right bundle branch block, and no abnormalties were found on a chest X-ray film.
F i g u r e 3 . Cl i n i c a l c o u r s e o f c a s e 2 . S h a d d e d a r e a i n d i c a t e s t h e n o r ma l r a n g e o f s e r u m p o t a s s i u m l e v e l s . P AC: p l a s ma a l d o s t e r o n e c o n c e n t r a t i o n , P RA: p l a s ma r e n i n a c t i v i t y . S B P : s y s t o l i c b l o o d p r e s s u r e .
No abnormalities were found in laboratory data including serum potassium level (Table 1) (Table 2) .
As shown in Fig. 3 , serum potassium levels were elevated to 4.0 mEq/l 7 days after potassium supplementation and blood pressure returned to normal by subsequent administration of spironolactone, 50 mg per day. PAC was still decreased (under 10 pg/ml), while serum cortisol level was normal (12.5 
μg/dl).
Discussion
The enzyme 11β-HSD2 catalyzes the conversion of cortisol to cortisone (12 (8, 9) . AME was distinguished clinically from Liddle's syndrome by the therapeutic response to spironolactone (7) .
In the present paper, 2 elderly women had the abnormalities similar to AME or Liddle's syndrome. They responded to blockade of mineralocorticoid receptor, suggesting an AME-like condition. Case 1 had no history of juvenile hypertension and blood pressure of case 2 was normal on admission. Therefore, their abnormalities were not ascribed to congenital impairment of the enzyme, although sequence analysis of 11β-HSD2 gene was not performed in the present patients.
It has been previously reported (7, 13) (7, 13, 16) . In the previous study (16) Elderly patients with an AME-like condition had been frequently described in recent reports (1) (2) (3) (4) (5) 
